Second line treatment Archives

Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer

Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.

Join our community Sign up for updates from Let’s Win!

Terms & Conditions • Privacy Policy

Please note that this information is not intended to be a substitute for professional medical opinion, advice or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.